Literature DB >> 9419347

Creation of monosomic derivatives of human cultured cell lines.

D J Clarke1, J F Giménez-Abián, H Tönnies, H Neitzel, K Sperling, C S Downes, R T Johnson.   

Abstract

Monosomic mammalian cell lines would be ideal for studying gene dosage effects, including gene imprinting, and for systematic isolation of recessive somatic mutants parallel to the invaluable mutants derived from haploid yeast. But autosomal monosomies are lethal in early development; although monosomies appear in tumors, deriving cell lines from these tumors is difficult and cannot provide several syngenic lines. We have developed a strategy for generating stable monosomic human cells, based on random autosomal integration of the gpt plasmid, partial inhibition of DNA topoisomerase II during mitosis to promote chromatid nondisjunction, and selection against retention of gpt. These are likely to be valuable as a source of otherwise inaccessible mutants. The strategy can also be used to generate partial mammalian monosomies, which are desirable as a source of information on recessive genes and gene imprinting.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9419347      PMCID: PMC18162          DOI: 10.1073/pnas.95.1.167

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Genetics of human cess line. IV. DNA-mediated heritable transformation of a biochemical trait.

Authors:  E H SZYBALSKA; W SZYBALSKI
Journal:  Proc Natl Acad Sci U S A       Date:  1962-12-15       Impact factor: 11.205

2.  Differences between rodent and human cell lines in the amount of integrated DNA after transfection.

Authors:  J H Hoeijmakers; H Odijk; A Westerveld
Journal:  Exp Cell Res       Date:  1987-03       Impact factor: 3.905

3.  Efficient transformation and frequent single-site, single-copy insertion of DNA can be obtained in mouse erythroleukemia cells transformed by electroporation.

Authors:  S S Boggs; R G Gregg; N Borenstein; O Smithies
Journal:  Exp Hematol       Date:  1986-11       Impact factor: 3.084

4.  Altered fidelity of mitotic chromosome transmission in cell cycle mutants of S. cerevisiae.

Authors:  L H Hartwell; D Smith
Journal:  Genetics       Date:  1985-07       Impact factor: 4.562

5.  The development of monosomy 19 mouse embryos.

Authors:  T Magnuson; S Smith; C J Epstein
Journal:  J Embryol Exp Morphol       Date:  1982-06

6.  Analysis of two-dimensional protein patterns from mouse embryos with different trisomies.

Authors:  J Klose; B Putz
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

7.  DNA topoisomerase II mutant of Saccharomyces cerevisiae: topoisomerase II is required for segregation of daughter molecules at the termination of DNA replication.

Authors:  S DiNardo; K Voelkel; R Sternglanz
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

8.  Chromosome engineering in mice.

Authors:  R Ramírez-Solis; P Liu; A Bradley
Journal:  Nature       Date:  1995-12-14       Impact factor: 49.962

9.  Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization.

Authors:  D Pinkel; T Straume; J W Gray
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

10.  Tsg101: a novel tumor susceptibility gene isolated by controlled homozygous functional knockout of allelic loci in mammalian cells.

Authors:  L Li; S N Cohen
Journal:  Cell       Date:  1996-05-03       Impact factor: 41.582

View more
  2 in total

1.  Analysis of sporadic neuroendocrine tumours of the enteropancreatic system by comparative genomic hybridisation.

Authors:  H Tönnies; M R Toliat; C Ramel; U F Pape; H Neitzel; W Berger; B Wiedenmann
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

2.  Cenp-E inhibitor GSK923295: Novel synthetic route and use as a tool to generate aneuploidy.

Authors:  Ailsa Bennett; Beatrice Bechi; Anthony Tighe; Sarah Thompson; David J Procter; Stephen S Taylor
Journal:  Oncotarget       Date:  2015-08-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.